These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 25677747)

  • 1. Targeting metabolic plasticity in breast cancer cells via mitochondrial complex I modulation.
    Xu Q; Biener-Ramanujan E; Yang W; Ramanujan VK
    Breast Cancer Res Treat; 2015 Feb; 150(1):43-56. PubMed ID: 25677747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adaptation of energy metabolism in breast cancer brain metastases.
    Chen EI; Hewel J; Krueger JS; Tiraby C; Weber MR; Kralli A; Becker K; Yates JR; Felding-Habermann B
    Cancer Res; 2007 Feb; 67(4):1472-86. PubMed ID: 17308085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dissecting tumor metabolic heterogeneity: Telomerase and large cell size metabolically define a sub-population of stem-like, mitochondrial-rich, cancer cells.
    Lamb R; Ozsvari B; Bonuccelli G; Smith DL; Pestell RG; Martinez-Outschoorn UE; Clarke RB; Sotgia F; Lisanti MP
    Oncotarget; 2015 Sep; 6(26):21892-905. PubMed ID: 26323205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid Assessment of Mitochondrial Complex I Activity and Metabolic Phenotyping of Breast Cancer Cells by NAD(p)H Cytometry.
    Ramanujan VK
    Cytometry A; 2019 Jan; 95(1):101-109. PubMed ID: 30536579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential Indexing of the Invasiveness of Breast Cancer Cells by Mitochondrial Redox Ratios.
    Sun N; Xu HN; Luo Q; Li LZ
    Adv Exp Med Biol; 2016; 923():121-127. PubMed ID: 27526133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor microenvironment and metabolic synergy in breast cancers: critical importance of mitochondrial fuels and function.
    Martinez-Outschoorn U; Sotgia F; Lisanti MP
    Semin Oncol; 2014 Apr; 41(2):195-216. PubMed ID: 24787293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondria as new therapeutic targets for eradicating cancer stem cells: Quantitative proteomics and functional validation via MCT1/2 inhibition.
    Lamb R; Harrison H; Hulit J; Smith DL; Lisanti MP; Sotgia F
    Oncotarget; 2014 Nov; 5(22):11029-37. PubMed ID: 25415228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of COX5B inhibits proliferation and promotes senescence via mitochondrial dysfunction in breast cancer.
    Gao SP; Sun HF; Jiang HL; Li LD; Hu X; Xu XE; Jin W
    Oncotarget; 2015 Dec; 6(41):43363-74. PubMed ID: 26506233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A combined approach against tumorigenesis using glucose deprivation and mitochondrial complex 1 inhibition by rotenone.
    Agarwal NR; Maurya N; Pawar JS; Ghosh I
    Cell Biol Int; 2016 Jul; 40(7):821-31. PubMed ID: 27109893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dermcidin exerts its oncogenic effects in breast cancer via modulation of ERBB signaling.
    Bancovik J; Moreira DF; Carrasco D; Yao J; Porter D; Moura R; Camargo A; Fontes-Oliveira CC; Malpartida MG; Carambula S; Vannier E; Strauss BE; Wakamatsu A; Alves VA; Logullo AF; Soares FA; Polyak K; Belizário JE
    BMC Cancer; 2015 Feb; 15():70. PubMed ID: 25879571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrially targeted vitamin E succinate efficiently kills breast tumour-initiating cells in a complex II-dependent manner.
    Yan B; Stantic M; Zobalova R; Bezawork-Geleta A; Stapelberg M; Stursa J; Prokopova K; Dong L; Neuzil J
    BMC Cancer; 2015 May; 15():401. PubMed ID: 25967547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-mitochondrial therapy in human breast cancer multi-cellular spheroids.
    Mandujano-Tinoco EA; Gallardo-Pérez JC; Marín-Hernández A; Moreno-Sánchez R; Rodríguez-Enríquez S
    Biochim Biophys Acta; 2013 Mar; 1833(3):541-51. PubMed ID: 23195224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-targeting of Cyclooxygenase-2 and FoxM1 is a viable strategy in inducing anticancer effects in colorectal cancer cells.
    Ahmed M; Hussain AR; Siraj AK; Uddin S; Al-Sanea N; Al-Dayel F; Al-Assiri M; Beg S; Al-Kuraya KS
    Mol Cancer; 2015 Jul; 14():131. PubMed ID: 26159723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary breast tumor-derived cellular models: characterization of tumorigenic, metastatic, and cancer-associated fibroblasts in dissociated tumor (DT) cultures.
    Drews-Elger K; Brinkman JA; Miller P; Shah SH; Harrell JC; da Silva TG; Ao Z; Schlater A; Azzam DJ; Diehl K; Thomas D; Slingerland JM; Perou CM; Lippman ME; El-Ashry D
    Breast Cancer Res Treat; 2014 Apr; 144(3):503-17. PubMed ID: 24567196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo metabolic evaluation of breast tumor mouse xenografts for predicting aggressiveness using the hyperpolarized (13)C-NMR technique.
    Xu HN; Kadlececk S; Pullinger B; Profka H; Cai K; Hariharan H; Rizi R; Li LZ
    Adv Exp Med Biol; 2013; 789():237-242. PubMed ID: 23852500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amyloid-β precursor protein promotes cell proliferation and motility of advanced breast cancer.
    Lim S; Yoo BK; Kim HS; Gilmore HL; Lee Y; Lee HP; Kim SJ; Letterio J; Lee HG
    BMC Cancer; 2014 Dec; 14():928. PubMed ID: 25491510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complex I and cytochrome c are molecular targets of flavonoids that inhibit hydrogen peroxide production by mitochondria.
    Lagoa R; Graziani I; Lopez-Sanchez C; Garcia-Martinez V; Gutierrez-Merino C
    Biochim Biophys Acta; 2011 Dec; 1807(12):1562-72. PubMed ID: 22015496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial mass, a new metabolic biomarker for stem-like cancer cells: Understanding WNT/FGF-driven anabolic signaling.
    Lamb R; Bonuccelli G; Ozsvári B; Peiris-Pagès M; Fiorillo M; Smith DL; Bevilacqua G; Mazzanti CM; McDonnell LA; Naccarato AG; Chiu M; Wynne L; Martinez-Outschoorn UE; Sotgia F; Lisanti MP
    Oncotarget; 2015 Oct; 6(31):30453-71. PubMed ID: 26421711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting respiratory complex I to prevent the Warburg effect.
    Vatrinet R; Iommarini L; Kurelac I; De Luise M; Gasparre G; Porcelli AM
    Int J Biochem Cell Biol; 2015 Jun; 63():41-5. PubMed ID: 25668477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.